Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
GRAIL, Inc.
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor
March 12, 2026
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
March 2, 2026
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
February 24, 2026
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
February 20, 2026
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results
February 16, 2026
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
February 3, 2026
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
←
Previous Page
1
2